The Vaccine and Infectious Disease Organization is a non-profit organization owned by the University of Saskatchewan and operates with financial support from the governments of Saskatchewan and Alberta as well as Government of Canada and industry competitive grants. In addition to the 100,000 sq ft (10,000 m2) facility on campus, VIDO also operates a 160-acre (0.6 km2) research station. VIDO is a member of three National Networks of Centres of Excellence: the Canadian Bacterial Diseases Network, the Canadian Network for Vaccines and Immunotherapeutics(CANVAC), and PrioNet. VIDO has created three spin-off companies (BIOSTAR Inc., BIOWEST, and STAR BIOTECH) and has worked with start-up companies including (PharmaDerm Laboratories, Taiga Bioactivities, Vetrepharm Canada Inc. and Inimex Veterinary Research).
HistoryInitially called the Veterinary Infectious Disease Organization, VIDO was established with funding from the Devonian Group of Charitable Foundations, the Province of Alberta and the Province of Saskatchewan. VIDO had strong ties to the University of Saskatchewan’s Western College of Veterinary Medicine. In March 2003, VIDO’s name was changed to the Vaccine and Infectious Disease Organization. In October a new 50,000 sq ft (5,000 m2) expansion was completed. In March 2004, VIDO received funding for the construction of a Biosafety Level 3 laboratory, the International Vaccine Centre (InterVac) for research into emerging and persistent human and animal diseases. Vaccines
Chief Executive Officer
External links
| |